Skip to main content

Krensavage Asset Management, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1609251 NEW YORK, NY

Position in REGN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$3,090,560
+$3,080 QoQ
Shares Held
4,000
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.21%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Krensavage Asset Management, LLC holds $143,120,529 across 9 Biotechnology names. REGN ranks #8 (2.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 REGN
Regeneron Pharmaceuticals, Inc.
This page
4,000 $3,090,560

All Filings in REGN

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,090,560 4,000
2025-12-31 $3,087,480 4,000
2025-09-30 $2,249,080 4,000
2025-06-30 $2,100,000 4,000
2024-09-30 $371,087 353
2024-06-30 $8,253,738 7,853
2024-03-31 $12,025,350 12,494
2023-12-31 $41,504,472 47,256
2023-09-30 $38,889,797 47,256
2023-06-30 $42,528,945 59,188
2023-03-31 $48,879,504 59,488
2022-12-31 $43,363,713 60,103
2022-09-30 $41,944,605 60,889
2022-06-30 $35,694,793 60,384
2022-03-31 $46,710,329 66,880
2021-12-31 $43,625,401 69,080
2021-09-30 $44,264,680 73,143
2021-06-30 $45,858,368 82,104
2021-03-31 $39,127,731 82,698
2020-12-31 $39,711,642 82,200
2020-09-30 $46,046,383 82,258
2020-06-30 $49,699,292 79,691
2020-03-31 $42,391,872 86,817